Introduction: Cardiac syncope heralds significantly higher mortality compared with
The search was performed for the period January 1, 1966 through December 31, 2017.
Studies were included for analysis if they met the following criteria: (a) published as a full-length article; (b) English language; (c) including greater than 100 individuals with a history of noncardiac or unexplained syncope; (d) with age greater than or equal to 18 years; (e) with greater than or equal to 1-year follow-up; and (f) reporting all-cause mortality of both individuals with and without noncardiac/ unexplained syncope, regardless of the site of presentation (ie, inpatient or outpatient).
| Data extraction and quality assessment
Two authors (FR and SP) performed the screening of titles and abstracts, reviewed full-text articles, and determined their eligibility.
The remaining authors acted as reviewers not blinded to the full texts of articles in consideration. Divergences were solved by consensus and/or involving the review by another author (RS).
We included four longitudinal studies with nonmatched control groups reporting on the long-term all-cause mortality outcome of patients with a first-time episode of noncardiac/unexplained syncope.
Two investigators (FR and CT) independently abstracted summarylevel data (ie, baseline characteristics, the number of events in each group, and the adjusted summary statistic) reported in original publications, using standardized data extraction. Syncope definition and case ascertainment across different selected studies are detailed in Table 1 . Two investigators (SP and GR) appraised the internal validity of included observational studies using the NewcastleOttawa Scale. This scale awards one up to nine stars judging each study in three main categories (ie, selection of study group, comparability, and ascertainment of the outcome of interest).
Divergences were solved by consensus and/or involving the review by another author (RS).
As we intended to use anonymized data from previous studies, the acceptance of Regional Ethical Review Board was not required, and the included studies were examined whether the Institutional Review Board clearance was obtained.
| Statistical analysis
The primary outcome was all-cause mortality. Outcome data were extracted as adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for and pooled in a random-effect, generic inverse variance meta-analysis to compute the summary effect size. Each study estimate of the relative condition was given a weight that was equal to the inverse of the variance of the effect estimate (ie, 1 divided by the squared SEM).
Heterogeneity of the effect across studies was assessed by means of the Cochrane Q (χ 2 ) and I 2 statistics. Lack of homogeneity was considered for Cochrane Q (χ 2 ) test of P less than or equal to 0.10 and/or for an I 2 statistics greater than or equal to 50%. When heterogeneity was judged significant, the pooled RR was calculated through the analysis of variance between studies with the "method of moments" or the Der Simonian and Laird method for random effects.
We computed the z-statistic for each clinical outcome, and considered results statistically significant at a P value less than 0.05 level.
We performed a leave-one-out sensitivity analysis, for each endpoint of interest, to evaluate the robustness of the results and the impact of each study on the summary estimate of effect; pooled estimates were recalculated multiple times, using a random effects model, each time with the removal of a single study from the baseline group. The likelihood of publication bias was visually assessed by generating a funnel plot, and evaluation by the Egger test of intercept: here, a P value less than 0.10 was considered as indicative of significant asymmetry. We also performed the nonparametric | 1643
analysis using a mixed-effects model to assess the effect of study- Figure 1 ). The average followup after the first-syncopal event was 4.4 years. The overall quality of studies was high, with one study scoring seven stars and three studies scoring nine stars (Newcastle-Ottawa Scale). The main characteristics of the included studies are summarized in Table 1 .
Compared with nonrandomized controls, a history of noncardiac or unexplained syncope was associated with a 13% increase in all-cause mortality (pooled adjusted HR = 1.13; 95% CI, 1.05 to 1.23) (Figure 2 ).
Publication bias, or "small study effect," was excluded by both visual inspection of the funnel plot and Egger test of intercept (Supporting Information Figure S1 ). Furthermore, the nonparametric "trim-and-fill" procedure could not impute any "missing" study.
"Leave-one-out" sensitivity analysis showed that no single study significantly affected the pooled aHR for all-cause mortality ( Table 2) .
Heterogeneity was moderate, but significant (I 2 > 50%; P < 0.10).
The univariate meta-regression analysis showed that the effect of noncardiac/unexplained syncope on mortality was higher with increasing age, and growing prevalence of diabetes and hypertension (Table 3) .
The four included studies were accepted by the appropriate Institutional Review Board at the main study site and the informed consent was obtained by the investigators for the United States and two Swedish studies, whereas the Danish study was accepted by the Danish Data Protection Agency as the ethical approval is not required for registry-based studies in Denmark. All patient-related data used for the meta-analysis were anonymized.
| DISCUSSION
This meta-analysis provides evidence that history of noncardiac syncope is associated with a moderate but significantly increased all-cause mortality. The association is stronger in older, diabetic, and hypertensive individuals, regardless of whether structural CVD was present or not.
Syncope is a not a specific diagnosis, it is only a symptom. According arrhythmia. 13 Although the ICD-10 diagnostic code for syncope demonstrates a very high positive accuracy for an actual syncopal event, 14 the role of a vasovagal reflex in the assessed event is not always obvious. Indeed, a vasovagal reflex-related etiology is frequently inferred by exclusion method (ie, by absence of cardiac or autonomic nervous system disease). It may be further confirmed by a typical history of past attacks, triggers, and prodromes. 15 However, some expertise is usually needed to identify reflex syncope adequately; and it should be borne in mind that autonomic nervous system disorders, such as OH and postural orthostatic tachycardia syndrome may mimic events caused by an isolated reflex syncope. Thus, the diagnostic code R55.9, although highly specific for loss of consciousness due to cerebral hypoperfusion, does not offer any specific information about its etiology. As administrative discharge codes are widely used in epidemiology, the ICD-10 code R55.9 should probably be revised to offer specific subcodes and proper discrimination of syncope etiologies.
After exclusion of cardiac syncope, the potential role of prevalent CVD in a recent syncopal episode may have been radically reduced, but not totally excluded for the reasons mentioned above. Hence, patients with prevalent CVD and unexplained syncope should be considered at high-risk, and need early hospital evaluation, including electrocardiography telemetry and, possibly, cardiac imaging, 15 especially those who are older, have diabetes or hypertension.
Traditionally, patients diagnosed with noncardiac syncope have been seen as a group with benign prognosis, especially at younger age, F I G U R E 2 All-cause mortality in patients with and without history of noncardiac syncope in the general population. FHS (3): hazard ratio adjusted for age, sex, smoking status, presence or absence of hypertension, systolic blood pressure, presence or absence of diabetes, total cholesterol level, heart rate, reported use or nonuse of cardiac medications (including antihypertensive medications), and presence or absence of a history of cardiovascular disease (myocardial infarction, coronary heart disease, stroke, congestive heart failure, atrial fibrillation, and intermittent claudication). DNPR (10): hazard ratio adjusted for age, sex, comorbidities (hypertension, ischemic heart disease, cerebral vascular disease, previous myocardial infarction, cardiac conduction disorders, cardiac arrhythmia, previous atrial fibrillation, heart failure or pulmonary edema, diabetes, acute or chronic renal failure, COPD, cancer, and liver disease), and concomitant pharmacotherapy. MPP (9): hazard ratio adjusted for age, sex, BMI, smoking, hypertension, diabetes, triglycerides, total cholesterol, history of cancer, atrial fibrillation, glomerular filtration rate, orthostatic hypotension, and antihypertensive medications. MDC (8) 
| Study limitations
We acknowledge some limitations requiring attention. Firstly, our analysis was based on aggregate summary-level data abstracted from original publications, but not on individual patient-level data. This prevented us from conducting in-depth subgroup or multivariate meta-regression analyses.
Secondly, unexplained and noncardiac syncope have been combined as one entity, though they may have significantly different risks of mortality. However, the diagnostic code R55.9 classification and lack of clinical data about systematic diagnostic work-up before ICD coding prevented us from segregating these two groups.
Thirdly, we found a significant statistical heterogeneity, possibly affecting the robustness of the results; nonetheless, we applied a rigorous statistical approach to explain heterogeneity and detected those study variables, particularly age, hypertension and diabetes, representing a possible source of the observed variability.
Finally, the absence of CVD in the various studies was commonly only evaluated at one single time point, so that recurrence of syncope and incident CVD were not accounted as possible additional confounding factors and/or effect modifiers.
| CONCLUSIONS
This study-level meta-analysis showed that among older, diabetic and/or hypertensive individuals, history of noncardiac/unexplained syncope, even in the absence of an obvious cardiac etiology, is associated with higher all-cause mortality. We suggest that in noncardiac/unexplained syncope, especially older, diabetic or hypertensive patients, a more proactive approach to cardiovascular risk assessment, including the use of long-term minimally invasive cardiac monitoring and other specific investigations, via syncope unit referral, may offer prophylactic measures and ultimately a reduction in this now identified mortality.
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